PDL BIOPHARMA, INC. (33) | Uncategorized (5)
Recent Contracts
-
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 29, 2021)
-
Asset Transfer Agreement dated as of August 11, 2020 between Defined Diagnostics, LLC (F/K/A Wellstat Diagnostics LLC) and the
(Filed With SEC on November 13, 2020)
-
Tax Matters Agreement, dated as of September 30, 2020, between PDL BioPharma, Inc. and LENSAR, Inc
(Filed With SEC on October 2, 2020)
-
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
(Filed With SEC on March 11, 2020)
-
Offer Letter between the Company and Ed Imbrogno
(Filed With SEC on June 24, 2019)
